Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections

Journal of Clinical Virology

Volumn 61, Issue 4, 2014, Pages 487-495

  Levin, Myron J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

DNAemia; Herpes zoster; Varicella; Varicella zoster virus; Viremia

Indexed keywords

ACICLOVIR; VARICELLA ZOSTER VACCINE; VIRUS DNA;

ANTIVIRAL THERAPY; BELL PALSY; BLOOD SAMPLING; CEREBROSPINAL FLUID; GENE DOSAGE; HERPES ZOSTER; HUMAN; IMMUNE STATUS; NEUROLOGIC DISEASE; OROPHARYNX; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RASH; REVIEW; SALIVA ANALYSIS; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION; ZOSTER SINE HERPETE; BLOOD; CHICKENPOX; ISOLATION AND PURIFICATION; PHYSIOLOGY; TIME; VIROLOGY; VIRUS LATENCY;

BLOOD; CHICKENPOX; DNA, VIRAL; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; OROPHARYNX; TIME FACTORS; VIRUS LATENCY;

EID: 84922680506     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.09.012     Document Type: Review

References (107)

1. Weller T.H., Stoddard M.B. Intranuclear inclusion bodies in cultures of human tissue inoculated with varicella vesicle fluid. J Immunol 1952, 68(3):311-319.
2. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55(4):611-622.
3. Gold E. Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection. N Engl J Med 1966, 274(4):181-185.
4. Mehta S.K., Tyring S.K., Cohrs R.J., Gilden D., Feiveson A.H., Lechler K.J., et al. Rapid and sensitive detection of varicella zoster virus in saliva of patients with herpes zoster. J Virol Methods 2013, 193(1):128-130.
5. Feldman S., Epp E. Isolation of varicellazoster virus from blood. J Pediatr 1976, 88(2):265-267.
6. Feldman S., Epp E. Detection of viremia during incubation of varicella. J Pediatr 1979, 94(5):746-748.
7. Myers M.G. Viremia caused by varicella-zoster virus: association with malignant progressive varicella. J Infect Dis 1979, 140(2):229-233.
8. Ozaki T., Ichikawa T., Matsui Y., Nagai T., Asano Y., Yamanishi K., et al. Viremic phase in nonimmunocompromised children with varicella. J Pediatr 1984, 104(1):85-87.
9. Asano Y., Itakura N., Hiroishi Y., Hirose S., Nagai T., Ozaki T., et al. Viremia is present in incubation period in nonimmunocompromised children with varicella. J Pediatr 1985, 106(1):69-71.
10. Ozaki T., Ichikawa T., Matsui Y., Kondo H., Nagai T., Asano Y., et al. Lymphocyte-associated viremia in varicella. J Med Virol 1986, 19(3):249-253.
11. Asano Y., Itakura N., Hiroishi Y., Hirose S., Ozaki T., Kuno K., et al. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis 1985, 152(5):863-868.
12. Asano Y., Itakura N., Kajita Y., Suga S., Yoshikawa T., Yazaki T., et al. Severity of viremia and clinical findings in children with varicella. J Infect Dis 1990, 161(6):1095-1098.
13. Ozaki T., Matsui Y., Asano Y., Okuno T., Yamanishi K., Takahashi M. Study of virus isolation from pharyngeal swabs in children with varicella. Am J Dis Child 1989, 143(12):1448-1450.
14. Trlifajova J., Bryndova D., Ryc M. Isolation of varicella-zoster virus from pharyngeal and nasal swabs in varicella patients. J Hyg Epidemiol Microbiol Immunol 1984, 28(2):201-206.
15. Pitel P.A., McCormick K.L., Fitzgerald E., Orson J.M. Subclinical hepatic changes in varicella infection. Pediatrics 1980, 65(3):631-633.
16. Meyer P.A., Seward J.F., Jumaan A.O., Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000, 182(2):383-390.
17. Feldman S., Hughes W.T., Daniel C.B. Varicella in children with cancer: seventy-seven cases. Pediatrics 1975, 56(3):388-397.
18. Grose C. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics 1981, 68(5):735-737.
19. Ku C.C., Besser J., Abendroth A., Grose C., Arvin A.M. Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol 2005, 79(5):2651-2658.
20. Vonsover A., Leventon-Kriss S., Langer A., Smetana Z., Zaizov R., Potaznick D., et al. Detection of varicella-zoster virus in lymphocytes by DNA hybridization. J Med Virol 1987, 21(1):57-66.
21. Koropchak C.M., Solem S.M., Diaz P.S., Arvin A.M. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J Virol 1989, 63(5):2392-2395.
22. Koropchak C.M., Graham G., Palmer J., Winsberg M., Ting S.F., Wallace M., et al. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J Infect Dis 1991, 163(5):1016-1022.
23. Kido S., Ozaki T., Asada H., Higashi K., Kondo K., Hayakawa Y., et al. Detection of varicella-zoster virus (VZV) DNA in clinical samples from patients with VZV by the polymerase chain reaction. J Clin Microbiol 1991, 29(1):76-79.
24. Sawyer M.H., Wu Y.N., Chamberlin C.J., Burgos C., Brodine S.K., Bowler W.A., et al. Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella. J Infect Dis 1992, 166(4):885-888.
25. Ozaki T., Masuda S., Asano Y., Kondo K., Namazue J., Yamanishi K. Investigation of varicella-zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination. J Med Virol 1994, 42(1):47-51.
26. Ozaki T., Kajita Y., Asano Y., Aono T., Yamanishi K. Detection of varicella-zoster virus DNA in blood of children with varicella. J Med Virol 1994, 44(3):263-265.
27. Mainka C., Fuss B., Geiger H., Hofelmayr H., Wolff M.H. Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol 1998, 56(1):91-98.
28. Kimura H., Kido S., Ozaki T., Tanaka N., Ito Y., Williams R.K., et al. Comparison of quantitations of viral load in varicella and zoster. J Clin Microbiol 2000, 38(6):2447-2449.
29. Ishizaki Y., Tezuka J., Ohga S., Nomura A., Suga N., Kuromaru R., et al. Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella. J Infect 2003, 47(2):133-138.
30. de Jong M.D., Weel J.F., Schuurman T., Wertheim-van Dillen P.M., Boom R. Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. J Clin Microbiol 2000, 38(7):2568-2573.
31. Ito Y., Kimura H., Hara S., Kido S., Ozaki T., Nishiyama Y., et al. Investigation of varicella-zoster virus DNA in lymphocyte subpopulations by quantitative PCR assay. Microbiol Immunol 2001, 45(3):267-269.
32. Malavige G.N., Jones L., Kamaladasa S.D., Wijewickrama A., Seneviratne S.L., Black A.P., et al. Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka. PLoS ONE 2008, 3(11):e3789.
33. Harbecke R., Oxman M.N., Arnold B.A., Ip C., Johnson G.R., Levin M.J., et al. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol 2009, 81(7):1310-1322.
34. Leung J., Harpaz R., Baughman A.L., Heath K., Loparev V., Vazquez M., et al. Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis 2010, 51(1):23-32.
35. Kronenberg A., Bossart W., Wuthrich R.P., Cao C., Lautenschlager S., Wiegand N.D., et al. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients. Transpl Infect Dis 2005, 7(3-4):116-121.
36. Levin M.J., Dahl K.M., Weinberg A., Giller R., Patel A., Krause P.R. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J Infect Dis 2003, 188(7):954-959.
37. Vossen M.T., Gent M.R., Peters K.M., Wertheim-van Dillen P.M., Dolman K.M., van Breda A., et al. Persistent detection of varicella-zoster virus DNA in a previously healthy child after severe chickenpox. J Clin Microbiol 2005, 43(11):5614-5621.
38. Ozaki T., Miwata H., Matsui Y. Varicella zoster virus DNA in throat swabs. Arch Dis Child 1990, 65:333-334.
39. Brunell P.A. Transmission of chickenpox in a school setting prior to the observed exanthem. Am J Dis Child 1989, 143(12):1451-1452.
40. Asano Y., Yoshikawa T., Ihira M., Furukawa H., Suzuki K., Suga S. Spread of varicella-zoster virus DNA to family members and environments from siblings with varicella in a household. Pediatrics 1999, 103(5):e61.
41. Asano Y., Yoshikawa T., Kanematsu M., Ihira M., Suzuki K., Suga S. Rapid contamination with varicella-zoster virus DNA to the throat of a daycare attendee and environmental surfaces from a child with varicella. Pediatr Int 1999, 41(2):233-236.
42. Suzuki K., Yoshikawa T., Ihira M., Ohashi M., Suga S., Asano Y. Spread of varicella-zoster virus DNA to the environment from varicella patients who were treated with oral acyclovir. Pediatr Int 2003, 45(4):458-460.
43. Connelly B.L., Stanberry L.R., Bernstein D.I. Detection of varicella-zoster virus DNA in nasopharyngeal secretions of immune household contacts of varicella. J Infect Dis 1993, 168(5):1253-1255.
44. Quinlivan M., Sengupta N., Papaevangelou V., Sauerbrei A., Grillner L., Rousseva R., et al. Use of oral fluid to examine the molecular epidemiology of varicella zoster virus in the United Kingdom and continental Europe. J Infect Dis 2013, 207(4):588-593.
45. Ozaki T., Miwata H., Asano J. Varicella zoster virus DNA in throat swabs of vaccinees. Arch Dis Child 1992, 67:328-329.
46. Weinmann S., Chun C., Schmid D.S., Roberts M., Vandermeer M., Riedlinger K., et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis 2013, 208(11):1859-1868.
47. Tsolia M., Gershon A.A., Steinberg S.P., Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J Pediatr 1990, 116(2):184-189.
48. Yamada M., Kamberos N., Grose C. Breakthrough varicella in a cancer patient with persistent varicella antibody after one varicella vaccination. J Pediatr 2013, 163(5):1511-1513.
49. Gershon A.A., Steinberg S., Silber R. Varicella-zoster viremia. J Pediatr 1978, 92(6):1033-1034.
50. Feldman S., Chaudary S., Ossi M., Epp E. A viremic phase for herpes zoster in children with cancer. J Pediatr 1977, 91(4):597-600.
51. Kalpoe J.S., Kroes A.C., Verkerk S., Claas E.C., Barge R.M., Beersma M.F. Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation. Bone Marrow Transplant 2006, 38(1):41-46.
52. Gilden D.H., Devlin M., Wellish M., Mahalingham R., Huff C., Hayward A., et al. Persistence of varicella-zoster virus DNA in blood mononuclear cells of patients with varicella or zoster. Virus Genes 1989, 2(4):299-305.
53. Gilden D.H., Hayward A.R., Krupp J., Hunter-Laszlo M., Huff J.C., Vafai A. Varicella-zoster virus infection of human mononuclear cells. Virus Res 1987, 7(2):117-129.
54. Vafai A., Wellish M., Gilden D.H. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci U S A 1988, 85(8):2767-2770.
55. Devlin M.E., Gilden D.H., Mahalingam R., Dueland A.N., Cohrs R. Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis 1992, 165(4):619-622.
56. Scott F.T., Leedham-Green M.E., Barrett-Muir W.Y., Hawrami K., Gallagher W.J., Johnson R., et al. A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol 2003, 70(Suppl 1):S24-S30.
57. Surman O.S., Flynn T., Schooley R.T., Baer L., Parker S., Hirsch M.S., et al. A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia. Psychosomatics 1990, 31(3):287-292.
58. Acosta E.P., Balfour H.H. Acyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokinetics. Antimicrob Agents Chemother 2001, 45(10):2771-2774.
59. Brisson M., Gay N.J., Edmunds W.J., Andrews N.J. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002, 20(19-20):2500-2507.
60. Hope-Simpson R.E. The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis. Proc R Soc Med 1965, 58:9-20.
61. Luby J.P., Ramirez-Ronda C., Rinner S., Hull A., Vergne-Marini P. A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis 1977, 135(4):659-663.
62. Ljungman P., Lonnqvist B., Gahrton G., Ringden O., Sundqvist V.A., Wahren B. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis 1986, 153(5):840-847.
63. Rasoul-Rockenschaub S., Zielinski C.C., Muller C., Tichatschek E., Popow-Kraupp T., Kunz C. Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancer. Cancer Immunol Immunother 1990, 31(3):191-195.
64. Wilson A., Sharp M., Koropchak C.M., Ting S.F., Arvin A.M. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis 1992, 165(1):119-126.
65. Gilden D.H., Dueland A.N., Cohrs R., Martin J.R., Kleinschmidt-DeMasters B.K., Mahalingam R. Preherpetic neuralgia. Neurology 1991, 41(8):1215-1218.
66. Dueland A.N., Devlin M., Martin J.R., Mahalingam R., Cohrs R., Manz H., et al. Fatal varicella-zoster virus meningoradiculitis without skin involvement. Ann Neurol 1991, 29(5):569-572.
67. Furuta Y., Ohtani F., Aizawa H., Fukuda S., Kawabata H., Bergstrom T. Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J 2005, 24(2):97-101.
68. Gilden D., Cohrs R.J., Mahalingam R., Nagel M.A. Neurological disease produced by varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol 2010, 342:243-253.
69. Terada K., Niizuma T., Kawano S., Kataoka N., Akisada T., Orita Y. Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete. J Med Virol 1998, 56(4):359-363.
70. Mahalingam R., Wellish M., Brucklier J., Gilden D.H. Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol 1995, 1(1):130-133.
71. Ito M., Nishihara H., Mizutani K., Kitamura K., Ihara T., Kamiya H., et al. Detection of varicella-zoster virus (VZV) DNA in throat swabs and peripheral blood mononuclear cells of immunocompromised patients with herpes zoster by polymerase chain reaction. Clin Diagn Virol 1995, 4(2):105-112.
72. Quinlivan M.L., Ayres K.L., Kelly P.J., Parker S.P., Scott F.T., Johnson R.W., et al. Persistence of varicella-zoster virus viraemia in patients with herpes zoster. J Clin Virol 2011, 50(2):130-135.
73. van der Beek M.T., Vermont C.L., Bredius R.G., Marijt E.W., van der Blij-de Brouwer C.S., Kroes A.C., et al. Persistence and antiviral resistance of varicella zoster virus in hematological patients. Clin Infect Dis 2013, 56(3):335-343.
74. Quinlivan M.L., Ayres K., Ran H., McElwaine S., Leedham-Green M., Scott F.T., et al. Effect of viral load on the outcome of herpes zoster. J Clin Microbiol 2007, 45(12):3909-3914.
75. Satyaprakash A.K., Tremaine A.M., Stelter A.A., Creed R., Ravanfar P., Mendoza N., et al. Viremia in acute herpes zoster. J Infect Dis 2009, 200(1):26-32.
76. Benbernou A., Drolet M., Levin M.J., Schmader K.E., Oxman M.N., Johnson R., et al. Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources. Eur J Pain 2011, 15(10):1100-1106.
77. Gilden D.H., Cohrs R.J., Mahalingam R. VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology 2005, 64(1):21-25.
78. Head H., Campbell A.W., Kennedy P.G. The pathology of Herpes Zoster and its bearing on sensory localisation. Rev Med Virol 1997, 7(3):131-143.
79. Schmidbauer M., Budka H., Pilz P., Kurata T., Hondo R. Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. Brain 1992, 115:383-398.
80. Furuta Y., Fukuda S., Suzuki S., Takasu T., Inuyama Y., Nagashima K. Detection of varicella-zoster virus DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete. J Med Virol 1997, 52(3):316-319.
81. Furuta Y., Ohtani F., Kawabata H., Fukuda S., Bergstrom T. High prevalence of varicella-zoster virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy. Clin Infect Dis 2000, 30(3):529-533.
82. Yamakawa K., Hamada M., Takeda T. Different real-time PCR assays could lead to a different result of detection of varicella-zoster virus in facial palsy. J Virol Methods 2007, 139(2):227-229.
83. Santos M.A.d. O., Filho H.H.C., Vianna M.F., Almeida A.G.d. P., Lazarini P.R. Varicella zoster virus in bell's palsy: a prospective study. Braz J Otorhinolaryngol 2010, 76(3):370-373.
84. Mehta S.K., Tyring S.K., Gilden D.H., Cohrs R.J., Leal M.J., Castro V.A., et al. Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis 2008, 197(5):654-657.
85. Nagel M.A., Choe A., Cohrs R.J., Traktinskiy I., Sorensen K., Mehta S.K., et al. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis 2011, 204(6):820-824.
86. Pierson D.L., Mehta S.K., Gilden D., Cohrs R.J., Nagel M.A., Schmid D.S., et al. Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization. J Infect Dis 2011, 203(11):1542-1545.
87. Mehta S.K., Cohrs R.J., Forghani B., Zerbe G., Gilden D.H., Pierson D.L. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 2004, 72(1):174-179.
88. Cohrs R.J., Mehta S.K., Schmid D.S., Gilden D.H., Pierson D.L. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol 2008, 80(6):1116-1122.
89. Mehta S.K., Laudenslager M.L., Stowe R.P., Crucian B.E., Sams C.F., Pierson D.L. Multiple latent viruses reactivate in astronauts during Space Shuttle missions. Brain Behav Immun 2014, (In press).
90. Uchakin P.N., Parish D.C., Dane F.C., Uchakina O.N., Scheetz A.P., Agarwal N.K., et al. Fatigue in medical residents leads to reactivation of herpes virus latency. Interdiscip Perspect Infect Dis 2011, 2011:571340.
91. Papaevangelou V., Quinlivan M., Lockwood J., Papaloukas O., Sideri G., Critselis E., et al. Subclinical VZV reaction in immunocompetent children hospitalized in the ICU associated with prolonged fever duration. Clin Microbiol Infect 2012, 19:E245-E251.
92. Gershon A.A. The history and mystery of VZV in saliva. J Infect Dis 2011, 204(6):815-816.
93. Gershon A.A., Gershon M.D. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev 2013, 26(4):728-743.
94. Viner K., Perella D., Lopez A., Bialek S., Newbern C., Pierre R., et al. Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings. J Infect Dis 2012, 205(9):1336-1341.
95. Krause P.R., Klinman D.M. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat Med 2000, 6(4):451-454.
96. Schunemann S., Mainka C., Wolff M.H. Subclinical reactivation of varicella-zoster virus in immunocompromised and immunocompetent individuals. Intervirology 1998, 41(2-3):98-102.
97. Schunemann S., Mainka C., Wolff M.H. No acute varicella-zoster virus replication in peripheral blood mononuclear cells during postherpetic neuralgia. Acta Virol 1999, 43(6):337-340.
98. Ordonez G., Pineda B., Garcia-Navarrete R., Sotelo J. Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis. Arch Neurol 2004, 61(4):529-532.
99. Toi C.S., Lay M.L., Lucas R., Chew C.B., Taylor J., Ponsonby A.L., et al. Varicella zoster virus quantitation in blood from symptomatic and asymptomatic individuals. J Med Virol 2013, 85(8):1491-1497.
100. Miller C.S., Avdiushko S.A., Kryscio R.J., Danaher R.J., Jacob R.J. Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol 2005, 43(5):2173-2180.
101. Compston L.I., Li C., Sarkodie F., Owusu-Ofori S., Opare-Sem O., Allain J.P. Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana. West Africa. J Med Virol 2009, 81(11):1860-1868.
102. Sachithanandham J., Ramamurthy M., Kannangai R., Daniel H.D., Abraham O.C., Rupali P., et al. Detection of opportunistic DNA viral infections by multiplex PCR among HIV infected individuals receiving care at a tertiary care hospital in South India. Indian J Med Microbiol 2009, 27(3):210-216.
103. Wang C.C., Yepes L.C., Danaher R.J., Berger J.R., Mootoor Y., Kryscio R.J., et al. Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109(2):232-237.
104. Chene A., Nylen S., Donati D., Bejarano M.T., Kironde F., Wahlgren M., et al. Effect of acute Plasmodium falciparum malaria on reactivation and shedding of the eight human herpes viruses. PLoS One 2011, 6(10):e26266.
105. Ricklin M.E., Lorscheider J., Waschbisch A., Paroz C., Mehta S.K., Pierson D.L., et al. T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology 2013, 81(2):174-181.
106. van Velzen M., Ouwendijk W.J., Selke S., Pas S.D., van Loenen F.B., Osterhaus A.D., et al. Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV. J Med Virol 2013, 85(9):1669-1677.
107. Birlea M., Cohrs R.J., Bos N., Mehta S.K., Pierson D.L., Gilden D. Search for varicella zoster virus DNA in saliva of healthy individuals aged 20-59 years. J Med Virol 2014, 86(2):360-362.